The optimal medical management of SIH and SID is not definitively specified, and insulin therapy remains the standard of care (16)
We call on the Government of India to urgently make GLP-1 receptor agonists, particularly in pre-filled syringe formulations, available to diabetes patients who need them most," said Deeksha Dev, another patient advocate associated with the Alignia Wellness Foundation
As we age or face stress, these communication pathways can become disrupted, leading to decreased vitality, slower recovery, and suboptimal health
Available from: 4 Morgan Stanley, 2023
Jeuveau has been evaluated in clinical studies for safety and approved by the FDA as safe for use in adults